神经囊尾蚴病脑积水:临床实践与研究挑战
本文综述神经囊尾蚴病脑积水的流行病学、实验研究、病理生理机制及临床手术管理争议。脑积水见于16%至51%的神经囊尾蚴病患者及64%至72%的脑外型患者。机械梗阻与炎症是关键机制,现行指南建议可切除活囊尾蚴者行囊肿切除,退变囊肿则行脑室腹腔分流并密切监测感染与故障。
要点
- 脑积水见于16%至51%的神经囊尾蚴病患者及64%至72%的脑外型患者。
- 可手术切除的活囊尾蚴所致脑积水推荐囊肿切除。
- 退变囊肿致炎症时手术风险高,应行脑室腹腔分流并密切监测感染与故障。
核心结论
- 机械梗阻与炎症是神经囊尾蚴病脑积水的关键病理生理机制。
- 驱虫药物与手术选择均有限制,实验模型有助于加深对疾病的理解。
研究设计与样本
- 本文为综合性文献综述,讨论神经囊尾蚴病脑积水的流行病学、实验研究、病理生理机制及临床手术管理争议。
主要发现
- 脑积水见于16%至51%的神经囊尾蚴病患者及64%至72%的脑外型患者。
- 动物模型已成功复制该病并开辟新的治疗途径前景。
关键数值与推荐
- 现行指南建议:脑积水由可手术切除的活囊尾蚴引起时,推荐囊肿切除。
- 退变囊肿伴蛋白释放致炎症时,手术切除风险高,应行脑室腹腔分流并密切监测感染与故障。
- 分流术后囊肿位于阻碍手术管理的脑区时,推荐驱虫治疗。
临床怎么用
- 根据囊肿活性与位置选择手术或分流策略,退变囊肿分流后需密切监测感染与故障。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The objective of this paper is to discuss relevant data on the epidemiology of hydrocephalus in neurocysticercosis, the new knowledge coming from experimental studies, the pathophysiological mechanisms involved, and the controversies regarding clinical and surgical management, through a comprehensive review of the literature. Hydrocephalus is present at the onset of the disease in 16% to 51% of patients with neurocysticercosis and in 64% to 72% of patients with the extraparenchymal form of the disease. Animal models have successfully reproduced the disease and open new therapeutic approaches perspectives. Current guidelines suggest that, when hydrocephalus is due to viable cysts that can be excised surgically, cyst removal is recommended. On the other hand, degenerating cysts with protein discharge become fixed and evoke inflammation throughout the cerebrospinal fluid compartments. In these cases, surgical removal is risky, and ventriculoperitoneal shunts should be placed with close monitoring of infection and malfunction. Cysticidal treatment after shunt surgery is recommended in cases of cysts located in cerebral areas that prevent surgical management. In conclusion, mechanical obstruction and inflammation are the key pathophysiologic mechanisms in the development of neurocysticercosis-induced hydrocephalus. Anthelmintic drugs and surgical options should be used, but they have limitations. A better understanding of the disease can come from experimental models.
引用
- Hamamoto Filho PT, Zanini MA, Fleury A, et al. Hydrocephalus in Neurocysticercosis: Challenges for Clinical Practice and Basic Research Perspectives. World Neurosurg. 2019. PMID: 30885859. doi:10.1016/j.wneu.2019.03.071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。